Mad in America

JANUARY 4, 2025

American psychiatry has weathered the crisis; it will not have to confront a public stunned by news of how the oft-cited 67% cumulative remission rate, in the largest and longest study ever done to evaluate depression treatment,” was born of scientific misconduct. Short of this, the best remaining course to take is a retraction.”

Neurotransmitters and mental health 145

Neurotransmitters and mental health Pharmaceuticals Sleep and mental health Aging and mental health 145

Mad in America

JANUARY 3, 2024

“By making these materials on depressive illness available, accessible in physicians’ offices all over the country, important information is effectively reaching the public in settings which encourage questions, discussion, treatment, or referral,” said NIMH director Lewis Judd. psychiatrists.

Neurotransmitters and mental health 144

Neurotransmitters and mental health Hospitality Education Self-awareness 144

Mad in America

NOVEMBER 6, 2023

667 In an NIMH study of 547 patients that compared six-year outcomes for depressed people treated for the disorder and those who eschewed medical treatment, the treated patients were three times more likely than untreated ones to suffer a cessation of their principal social role and nearly seven times more likely to become incapacitated.

Bipolar disorder 145

Bipolar disorder Neurotransmitters and mental health Genetics and mental health Aging and mental health 145

Mad in America

MARCH 15, 2025

Joanna Moncrieff, Chemically Imbalanced (2025) E stablishment psychiatry has recently switched the biological cause of mental illness from a chemical imbalance to a brain circuitry defect. Establishment psychiatry has shown this same unscientific thinking in its manufacturing of other biological theories of mental illness.

Neurotransmitters and mental health 130

Neurotransmitters and mental health Trauma and the brain Manufacturing Pharmaceuticals 130